Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Intrinsic Value
Dr. Reddy's Laboratories Ltd. engages in the manufacture and marketing of pharmaceutical products. [ Read More ]
The intrinsic value of one
DRREDDY
stock under the Base Case scenario is
5 328.18
INR.
Compared to the current market price of 6 022.75 INR,
Dr Reddy's Laboratories Ltd
is
Overvalued by 12%.
Dr Reddy's Laboratories Ltd's market capitalization is 1T INR.
DRREDDY stock price is 6 022.75 INR.
DRREDDY stock (5 328.18 INR) is 12% less than its price (6022.75 INR).
DRREDDY stock (4 009.85 INR) is 33% less than its price (6022.75 INR). Open DCF Valuation
DRREDDY stock price (6022.75 INR) is 9% less than its Relative Value (6 646.52 INR). Open Relative Valuation
DRREDDY has upside potential of 0% compared to the average analyst price target.
Open Wall St Estimates
DRREDDY has positive Net Income for the last twelve months.
DRREDDY's Revenue has grown by 14% over the past 12 months.
DRREDDY's Revenue is forecast to grow at a rate of 9% per year over the next 3 years.
DRREDDY has positive three-year average ROIC (Return on Invested Capital): 14%. The company is efficient at using invested capital to generate operating income.
DRREDDY's ROIC (Return on Invested Capital) for the past 12 months is positive and is equal to 19%.
DRREDDY's ROIC (Return on Invested Capital) has increased in the last 3 years from 11% to 19%.
DRREDDY has positive Operating Income for the last twelve months.
DRREDDY's ROE (Return on Equity) for the past 12 months is positive and is equal to 23%.
DRREDDY has positive three-year average ROE (Return on Equity): 16%. The company is efficient at transforming stockholders' equity into net income.
DRREDDY's ROE (Return on Equity) has significantly increased in the last 3 years from 12% to 23%.
DRREDDY's Revenue has been growing by 13% per year for the last 3 years.
DRREDDY has positive Free Cash Flow for the last twelve months.
DRREDDY's short-term assets (217B INR) exceed its short-term liabilties (84B INR).
DRREDDY has positive Gross Profit for the last twelve months.
DRREDDY's long-term assets (348B INR) exceed its long-term liabilties (93B INR).
DRREDDY's D/E (Debt to Equity) is very low and is equal to 0.02.
DRREDDY has negative Net Debt. This means that the company has more cash and short-term investments (73B INR) than debt (6B INR).
DRREDDY's Altman Z-Score is very high and is equal to 8.83.
DRREDDY earns more than enough operating income (63B INR) to safely cover interest payments on its debt (2B INR).
Valuation Backtest
Dr Reddy's Laboratories Ltd
Run backtest to discover the historical profit from buying and selling
DRREDDY
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Dr Reddy's Laboratories Ltd
Balance Sheet Decomposition
Dr Reddy's Laboratories Ltd
| Current Assets | 217.4B |
| Cash & Short-Term Investments | 72.5B |
| Receivables | 69.7B |
| Other Current Assets | 75.2B |
| Non-Current Assets | 130.7B |
| Long-Term Investments | 6.7B |
| PP&E | 70B |
| Intangibles | 42.4B |
| Other Non-Current Assets | 11.6B |
| Current Liabilities | 84.1B |
| Accounts Payable | 27.3B |
| Other Current Liabilities | 56.8B |
| Non-Current Liabilities | 9.1B |
| Long-Term Debt | 6B |
| Other Non-Current Liabilities | 3B |
Earnings Waterfall
Dr Reddy's Laboratories Ltd
|
Revenue
|
272.1B
INR
|
|
Cost of Revenue
|
-80.1B
INR
|
|
Gross Profit
|
192B
INR
|
|
Operating Expenses
|
-129.2B
INR
|
|
Operating Income
|
62.8B
INR
|
|
Other Expenses
|
-10.5B
INR
|
|
Net Income
|
52.3B
INR
|
Free Cash Flow Analysis
Dr Reddy's Laboratories Ltd
DRREDDY Profitability Score
Profitability Due Diligence
Dr Reddy's Laboratories Ltd's profitability score is 64/100. The higher the profitability score, the more profitable the company is.
Score
Dr Reddy's Laboratories Ltd's profitability score is 64/100. The higher the profitability score, the more profitable the company is.
DRREDDY Solvency Score
Solvency Due Diligence
Dr Reddy's Laboratories Ltd's solvency score is 95/100. The higher the solvency score, the more solvent the company is.
Score
Dr Reddy's Laboratories Ltd's solvency score is 95/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
DRREDDY Price Targets Summary
Dr Reddy's Laboratories Ltd
According to Wall Street analysts, the average 1-year price target for
DRREDDY
is 6 027.59 INR
with a low forecast of 3 954.15 INR and a high forecast of 7 124.25 INR.
Shareholder Return
DRREDDY Price
Dr Reddy's Laboratories Ltd
| Average Annual Return | 16.03% |
| Standard Deviation of Annual Returns | 45.06% |
| Max Drawdown | -13% |
| Market Capitalization | 1T INR |
| Shares Outstanding | 166 464 436 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Dr Reddy's Laboratories Ltd
Country
Industry
Market Cap
Dividend Yield
Description
Dr. Reddy's Laboratories Ltd. engages in the manufacture and marketing of pharmaceutical products. The company is headquartered in Hyderabad, Telangana and currently employs 22,739 full-time employees. The Company’s segments include Global Generics, which is engaged in manufacturing and marketing prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics); Pharmaceutical Services and Active Ingredients (PSAI), which is engaged in manufacturing and marketing active pharmaceutical ingredients and intermediates for finished pharmaceutical products; Proprietary Products, which focuses on research and development of differentiated formulations and Others, which consists of the Company’s wholly-owned subsidiary, Aurigene Discovery Technologies Limited, which is a discovery stage biotechnology company developing novel and therapies in the fields of oncology and inflammation.
Contact
IPO
Employees
Officers
The intrinsic value of one
DRREDDY
stock under the Base Case scenario is
5 328.18
INR.
Compared to the current market price of 6 022.75 INR,
Dr Reddy's Laboratories Ltd
is
Overvalued by 12%.
You don't have any saved screeners yet
